162 related articles for article (PubMed ID: 38185200)
1. Oocyte vitrification for fertility preservation is an evolving practice requiring a new mindset: societal, technical, clinical, and basic science-driven evolutions.
Cimadomo D; Cobo A; Galliano D; Fiorentino G; Marconetto A; Zuccotti M; Rienzi L
Fertil Steril; 2024 Apr; 121(4):555-561. PubMed ID: 38185200
[TBL] [Abstract][Full Text] [Related]
2. Oocyte vitrification for elective fertility preservation: a SWOT analysis.
Gil-Arribas E; Blockeel C; Pennings G; Nekkebroeck J; Velasco JAG; Serna J; De Vos M
Reprod Biomed Online; 2022 Jun; 44(6):1005-1014. PubMed ID: 35304091
[TBL] [Abstract][Full Text] [Related]
3. Oocyte vitrification for oncological and social reasons.
Köroğlu N; Aydın T
Turk J Obstet Gynecol; 2023 Mar; 20(1):59-63. PubMed ID: 36908095
[TBL] [Abstract][Full Text] [Related]
4. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F;
Fertil Steril; 2017 Sep; 108(3):407-415.e11. PubMed ID: 28739117
[TBL] [Abstract][Full Text] [Related]
5. Successful elective and medically indicated oocyte vitrification and warming for autologous in vitro fertilization, with predicted birth probabilities for fertility preservation according to number of cryopreserved oocytes and age at retrieval.
Doyle JO; Richter KS; Lim J; Stillman RJ; Graham JR; Tucker MJ
Fertil Steril; 2016 Feb; 105(2):459-66.e2. PubMed ID: 26604065
[TBL] [Abstract][Full Text] [Related]
6. Postponing Pregnancy Through Oocyte Cryopreservation for Social Reasons: Considerations Regarding Clinical Practice and the Socio-Psychological and Bioethical Issues Involved.
Simopoulou M; Sfakianoudis K; Bakas P; Giannelou P; Papapetrou C; Kalampokas T; Rapani A; Chatzaki E; Lambropoulou M; Lourida C; Deligeoroglou E; Pantos K; Koutsilieris M
Medicina (Kaunas); 2018 Oct; 54(5):. PubMed ID: 30366459
[TBL] [Abstract][Full Text] [Related]
7. Oocyte vitrification for fertility preservation for both medical and nonmedical reasons.
Cobo A; García-Velasco JA; Remohí J; Pellicer A
Fertil Steril; 2021 May; 115(5):1091-1101. PubMed ID: 33933172
[TBL] [Abstract][Full Text] [Related]
8. Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives.
Maggiulli R; Vaiarelli A; Cimadomo D; Giancani A; Tacconi L; Fabozzi G; Ubaldi FM; Rienzi L
J Vis Exp; 2021 Sep; (175):. PubMed ID: 34605809
[TBL] [Abstract][Full Text] [Related]
9. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
10. A web-based survey of reproductive awareness and choices in women with endometriosis.
Navarria-Forney I; Bénard J; Mazloum A; Aerts L; Pluchino N; Streuli I
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():106-113. PubMed ID: 32497984
[TBL] [Abstract][Full Text] [Related]
11. Preservation of female fertility: The current therapeutic strategy.
Henry L; Labied S; Jouan C; Nisolle M
Int J Gynaecol Obstet; 2022 Jan; 156(1):3-9. PubMed ID: 33829509
[TBL] [Abstract][Full Text] [Related]
12. Oocyte vitrification as an efficient option for elective fertility preservation.
Cobo A; García-Velasco JA; Coello A; Domingo J; Pellicer A; Remohí J
Fertil Steril; 2016 Mar; 105(3):755-764.e8. PubMed ID: 26688429
[TBL] [Abstract][Full Text] [Related]
13. ESHRE guideline: female fertility preservation.
; Anderson RA; Amant F; Braat D; D'Angelo A; Chuva de Sousa Lopes SM; Demeestere I; Dwek S; Frith L; Lambertini M; Maslin C; Moura-Ramos M; Nogueira D; Rodriguez-Wallberg K; Vermeulen N
Hum Reprod Open; 2020; 2020(4):hoaa052. PubMed ID: 33225079
[TBL] [Abstract][Full Text] [Related]
14. Planned Oocyte Cryopreservation: A Review of Current Evidence on Outcomes, Safety and Risks.
Song BB; Quinn MM
Obstet Gynecol Clin North Am; 2023 Dec; 50(4):707-719. PubMed ID: 37914489
[TBL] [Abstract][Full Text] [Related]
15. Oocyte cryopreservation: where are we now?
Argyle CE; Harper JC; Davies MC
Hum Reprod Update; 2016 Jun; 22(4):440-9. PubMed ID: 27006004
[TBL] [Abstract][Full Text] [Related]
16. Five years' experience using oocyte vitrification to preserve fertility for medical and nonmedical indications.
Garcia-Velasco JA; Domingo J; Cobo A; Martínez M; Carmona L; Pellicer A
Fertil Steril; 2013 Jun; 99(7):1994-9. PubMed ID: 23465707
[TBL] [Abstract][Full Text] [Related]
17. Oocyte vitrification for elective fertility preservation: the past, present, and future.
Gunnala V; Schattman G
Curr Opin Obstet Gynecol; 2017 Feb; 29(1):59-63. PubMed ID: 27922944
[TBL] [Abstract][Full Text] [Related]
18. [Ovocyte vitrification: a tool for the future].
Boyer P; Montjean D; Siraudin C; Gervoise-Boyer M
Biol Aujourdhui; 2015; 209(2):167-74. PubMed ID: 26514386
[TBL] [Abstract][Full Text] [Related]
19. Oocyte vitrification offers more space for a tailored surgical management of endometriosis.
Pluchino N; Roman H
Reprod Biomed Online; 2020 Nov; 41(5):753-755. PubMed ID: 32819840
[TBL] [Abstract][Full Text] [Related]
20. Elective oocyte cryopreservation for age-related fertility decline.
Chronopoulou E; Raperport C; Sfakianakis A; Srivastava G; Homburg R
J Assist Reprod Genet; 2021 May; 38(5):1177-1186. PubMed ID: 33608838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
